Brinter Inc
February 26, 2024
Medical Devices
.png' width='440' height='83.8169563675062' border='0' style='border-style: none;'>)
BRINTER, a first-mover US medical technology firm with 3D bioprinted universal human cartilage platform (BioMods™) for the $10B+ cartilage repair market.
Our first 510(k) Nose-BioMod™ product is estimated to be commercial in mid-2026.
Our bioengineered universal cartilage BioMods™ with regenerative medicine design eliminates the need for painful and expensive patient cartilage harvest/allografts in facial reconstruction and plastic/metal implants in the meniscus, hip, and shoulder tear treatments.
)
){kind=logo}
)
){kind=logo}
){kind=logo}